Anti-ZSCAN1 Autoantibodies Are a Feasible Diagnostic Marker for ROHHAD Syndrome Not Associated with a TumorAkari Nakamura‐Utsunomiya(Hiroshima University), Naoki Goshima(National Institute of Advanced Industrial Science and Technology)International Journal of Molecular SciencesFebruary 1, 202410.3390/ijms25031794Cited by 11SaveCiteExport RISWatch citationsRelated PapersExpression screening of 17q12–21 amplicon reveals GRB7 as an ERBB2‐dependent oncogene|FEBS Letters|2012|30